Oramed Pharmaceuticals Inc. - Common Stock (NQ:ORMP)

4.160 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Oramed Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 Next >

LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years ↗

February 20, 2026

The company announced it would implement a 1-for-12 reverse stock split effective Feb. 24, 2026.

Via Stocktwits

CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround ↗

February 03, 2026

CarMax runs a nationwide network of used car stores and digital channels, offering multi-channel sales and financing to U.S. consumers.

Via The Motley Fool

Topics Regulatory Compliance

Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter. ↗

February 03, 2026

This clinical-stage biotech develops therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition.

Via The Motley Fool

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 06, 2025

Via Benzinga

Congressional Trading Report: Rep. Brad Knott Sold Over $15K In Oramed Pharmaceuticals Stock ↗

February 26, 2025

Via Benzinga

Unusual volume stocks in Wednesday's session ↗

February 12, 2025

On Wednesday, there are stocks with unusual volume. Let's take a look.

Via Chartmill

What's going on in today's session ↗

February 11, 2025

Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024 ↗

August 19, 2024

ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

3 Micro-Cap Moonshots for Fearless Investors ↗

July 08, 2024

Investors should know the risks of micro-cap stocks before looking into these three high-potential companies with low prices.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 12, 2024

Via Benzinga

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q1 2024 ↗

May 09, 2024

ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023 ↗

March 07, 2024

ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Top 4 Health Care Stocks That May Crash This Quarter ↗

February 02, 2024

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations ↗

August 05, 2023

Mundipharma is considering selling its China operations in a deal that could be worth $1 billion. Additionally, Oramed Pharma plans to form a $60 million JV with Hefei Tianhui Biotech to commercialize...

Via Talk Markets

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 23, 2023

Via Benzinga

Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 23, 2023

Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.

Via Benzinga

Dow Tumbles 250 Points; CarMax Posts Upbeat Results ↗

June 23, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday. Following the market opening Friday, the Dow traded down 0.74% to 33,695.28 while the NASDAQ fell 0.98%...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 16, 2023

Via Benzinga

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 15, 2023

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Via Benzinga

Why Oramed Pharmaceuticals Shares Are Trading Higher Today ↗

May 15, 2023

Oramed Pharmaceuticals Inc (NASDAQ: ORMP) shares are trading higher after its partner completed Phase 3 trials of oral insulin in type 2 diabetes in China

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

January 19, 2023

On Thursday, 29 stocks made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 17, 2023

Tuesday saw 9 companies set new 52-week lows.

Via Benzinga

Gold Tops $1,900 After US CPI Report, S&P 500 Rises 0.5% ↗

January 12, 2023

U.S. stocks traded higher toward the end of trading, following the release of inflation data.

Via Benzinga

Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 12, 2023

Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023 ↗

January 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 12, 2023

Via Benzinga

Wall Street Divided After Key Inflation Reading ↗

January 12, 2023

Stocks are a mixed bag midday, despite this morning's encouraging consumer price index (CPI).

Via Talk Markets

US Stocks Turn Higher; Dow Jumps 200 Points ↗

January 12, 2023

U.S. stocks turned higher midway through trading, following the release of inflation data.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

January 12, 2023

On Thursday, 13 stocks hit new 52-week lows.

Via Benzinga

Why Oramed Pharmaceuticals Stock Is Crashing Today ↗

January 12, 2023

The company's lead pipeline candidate is still being evaluated as a potential treatment for NASH after a major flop in treating type 2 diabetes.

Via The Motley Fool

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.